The demand for higher value from pharmaceuticals and medical devices is increasing. Risk-based monitoring can reduce the development time of safe and effective products at lower cost.
The demand for higher value from pharmaceuticals and medical devices has never been greater. Risk-based monitoring can help speed the development of safe and effective products at lower cost.
PwC has tapped the knowledge and experience of multiple industries to develop a systematic approach to developing and deploying a risk-based monitoring platform that has the potential to increase patient safety and data quality while significantly reducing development costs. This new platform combines four different monitoring approaches into one holistic strategy, which trial sponsors can intelligently tailor for each study and site through an algorithmic method of risk prediction.